SIGNIFICANCE OF SINGLE-NUCLEOTIDE POLYMORPHISMS 2578C>A AND +936C>T IN THE VEGF GENE FOR EFFICIENCY EVALUAT ION OF ANTICANCER IMMUNOTHERAPY IN PAT IENTS WITH METASTAT IC SKIN MELANOMA

Abstract. Increased VEGF levels in cancer patients may be associated with decreased number of dendritic cells (DCs) and lower DC function. We investigated whether VEGF gene polymorphisms -2578C>A (rs699947) and +936C>T (rs3025039) are associated with efficacy of autologous DC-based imm...

Full description

Bibliographic Details
Main Authors: Yu. A. Khochenkova, G. Z. Chkadua, I. V. Samoylenko, T. F. Malivanova, I. N. Mikhailova, L. V. Demidov, E. V. Stepanova
Format: Article
Language:Russian
Published: St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2014-07-01
Series:Медицинская иммунология
Subjects:
Online Access:https://www.mimmun.ru/mimmun/article/view/671
_version_ 1797198057959325696
author Yu. A. Khochenkova
G. Z. Chkadua
I. V. Samoylenko
T. F. Malivanova
I. N. Mikhailova
L. V. Demidov
E. V. Stepanova
author_facet Yu. A. Khochenkova
G. Z. Chkadua
I. V. Samoylenko
T. F. Malivanova
I. N. Mikhailova
L. V. Demidov
E. V. Stepanova
author_sort Yu. A. Khochenkova
collection DOAJ
description Abstract. Increased VEGF levels in cancer patients may be associated with decreased number of dendritic cells (DCs) and lower DC function. We investigated whether VEGF gene polymorphisms -2578C>A (rs699947) and +936C>T (rs3025039) are associated with efficacy of autologous DC-based immunotherapy in patients with malignant melanoma. Evaluation of VEGFR-1 and VEGFR-2 expression on mature monocyte-derived DC revealed a decreased VEGFR-1 level (18.9±0.7% on peripheral blood monocytes, as compared to 6.3±0.6% on mature DCs) and non-changed VEGFR-2 expression (13.1±0.4% and 15.9±0.4%, respectively). The АА genotype frequency of -2578C>A (rs699947) polymorphism of VEGF gene was 46.1%. АС heterozygous state was found in 38.5%, and СС, in 15.4% of cases. The VEGF -2578 AC and AA genotypes were directly associated with progression-free survival and efficacy of treatment. The median progression-free survival of patients with -2578 AA and AC genotypes was a significantly longer (8.4 months), as compared with that of patients with CC genotypes (2.7 months), p = 0.002. The established relationship between genotype and efficacy of immunotherapy can be used to develop modern methods for predicting melanoma progression and to personalize immunotherapy including a combination with antiangiogenic therapy.
first_indexed 2024-03-08T05:50:13Z
format Article
id doaj.art-eeb026a56774434f9e4bf5856688d7d3
institution Directory Open Access Journal
issn 1563-0625
2313-741X
language Russian
last_indexed 2024-04-24T06:53:49Z
publishDate 2014-07-01
publisher St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
record_format Article
series Медицинская иммунология
spelling doaj.art-eeb026a56774434f9e4bf5856688d7d32024-04-22T13:07:39ZrusSt. Petersburg branch of the Russian Association of Allergologists and Clinical ImmunologistsМедицинская иммунология1563-06252313-741X2014-07-0115656357010.15789/1563-0625-2013-6-563-570668SIGNIFICANCE OF SINGLE-NUCLEOTIDE POLYMORPHISMS 2578C>A AND +936C>T IN THE VEGF GENE FOR EFFICIENCY EVALUAT ION OF ANTICANCER IMMUNOTHERAPY IN PAT IENTS WITH METASTAT IC SKIN MELANOMAYu. A. Khochenkova0G. Z. Chkadua1I. V. Samoylenko2T. F. Malivanova3I. N. Mikhailova4L. V. Demidov5E. V. Stepanova6N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowN.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowN.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowN.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowN.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowN.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowN.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowAbstract. Increased VEGF levels in cancer patients may be associated with decreased number of dendritic cells (DCs) and lower DC function. We investigated whether VEGF gene polymorphisms -2578C>A (rs699947) and +936C>T (rs3025039) are associated with efficacy of autologous DC-based immunotherapy in patients with malignant melanoma. Evaluation of VEGFR-1 and VEGFR-2 expression on mature monocyte-derived DC revealed a decreased VEGFR-1 level (18.9±0.7% on peripheral blood monocytes, as compared to 6.3±0.6% on mature DCs) and non-changed VEGFR-2 expression (13.1±0.4% and 15.9±0.4%, respectively). The АА genotype frequency of -2578C>A (rs699947) polymorphism of VEGF gene was 46.1%. АС heterozygous state was found in 38.5%, and СС, in 15.4% of cases. The VEGF -2578 AC and AA genotypes were directly associated with progression-free survival and efficacy of treatment. The median progression-free survival of patients with -2578 AA and AC genotypes was a significantly longer (8.4 months), as compared with that of patients with CC genotypes (2.7 months), p = 0.002. The established relationship between genotype and efficacy of immunotherapy can be used to develop modern methods for predicting melanoma progression and to personalize immunotherapy including a combination with antiangiogenic therapy.https://www.mimmun.ru/mimmun/article/view/671vegfsnpsdendritic cellsanticancer immunotherapymetastatic melanoma
spellingShingle Yu. A. Khochenkova
G. Z. Chkadua
I. V. Samoylenko
T. F. Malivanova
I. N. Mikhailova
L. V. Demidov
E. V. Stepanova
SIGNIFICANCE OF SINGLE-NUCLEOTIDE POLYMORPHISMS 2578C>A AND +936C>T IN THE VEGF GENE FOR EFFICIENCY EVALUAT ION OF ANTICANCER IMMUNOTHERAPY IN PAT IENTS WITH METASTAT IC SKIN MELANOMA
Медицинская иммунология
vegf
snps
dendritic cells
anticancer immunotherapy
metastatic melanoma
title SIGNIFICANCE OF SINGLE-NUCLEOTIDE POLYMORPHISMS 2578C>A AND +936C>T IN THE VEGF GENE FOR EFFICIENCY EVALUAT ION OF ANTICANCER IMMUNOTHERAPY IN PAT IENTS WITH METASTAT IC SKIN MELANOMA
title_full SIGNIFICANCE OF SINGLE-NUCLEOTIDE POLYMORPHISMS 2578C>A AND +936C>T IN THE VEGF GENE FOR EFFICIENCY EVALUAT ION OF ANTICANCER IMMUNOTHERAPY IN PAT IENTS WITH METASTAT IC SKIN MELANOMA
title_fullStr SIGNIFICANCE OF SINGLE-NUCLEOTIDE POLYMORPHISMS 2578C>A AND +936C>T IN THE VEGF GENE FOR EFFICIENCY EVALUAT ION OF ANTICANCER IMMUNOTHERAPY IN PAT IENTS WITH METASTAT IC SKIN MELANOMA
title_full_unstemmed SIGNIFICANCE OF SINGLE-NUCLEOTIDE POLYMORPHISMS 2578C>A AND +936C>T IN THE VEGF GENE FOR EFFICIENCY EVALUAT ION OF ANTICANCER IMMUNOTHERAPY IN PAT IENTS WITH METASTAT IC SKIN MELANOMA
title_short SIGNIFICANCE OF SINGLE-NUCLEOTIDE POLYMORPHISMS 2578C>A AND +936C>T IN THE VEGF GENE FOR EFFICIENCY EVALUAT ION OF ANTICANCER IMMUNOTHERAPY IN PAT IENTS WITH METASTAT IC SKIN MELANOMA
title_sort significance of single nucleotide polymorphisms 2578c a and 936c t in the vegf gene for efficiency evaluat ion of anticancer immunotherapy in pat ients with metastat ic skin melanoma
topic vegf
snps
dendritic cells
anticancer immunotherapy
metastatic melanoma
url https://www.mimmun.ru/mimmun/article/view/671
work_keys_str_mv AT yuakhochenkova significanceofsinglenucleotidepolymorphisms2578caand936ctinthevegfgeneforefficiencyevaluationofanticancerimmunotherapyinpatientswithmetastaticskinmelanoma
AT gzchkadua significanceofsinglenucleotidepolymorphisms2578caand936ctinthevegfgeneforefficiencyevaluationofanticancerimmunotherapyinpatientswithmetastaticskinmelanoma
AT ivsamoylenko significanceofsinglenucleotidepolymorphisms2578caand936ctinthevegfgeneforefficiencyevaluationofanticancerimmunotherapyinpatientswithmetastaticskinmelanoma
AT tfmalivanova significanceofsinglenucleotidepolymorphisms2578caand936ctinthevegfgeneforefficiencyevaluationofanticancerimmunotherapyinpatientswithmetastaticskinmelanoma
AT inmikhailova significanceofsinglenucleotidepolymorphisms2578caand936ctinthevegfgeneforefficiencyevaluationofanticancerimmunotherapyinpatientswithmetastaticskinmelanoma
AT lvdemidov significanceofsinglenucleotidepolymorphisms2578caand936ctinthevegfgeneforefficiencyevaluationofanticancerimmunotherapyinpatientswithmetastaticskinmelanoma
AT evstepanova significanceofsinglenucleotidepolymorphisms2578caand936ctinthevegfgeneforefficiencyevaluationofanticancerimmunotherapyinpatientswithmetastaticskinmelanoma